A unique, easy to use antibiotic will be launched in February by ECO Animal Health offering the “simplest, most effective” control of the challenging Mycoplasma respiratory disease in pheasants.
A unique, easy to use antibiotic will be launched in February by ECO Animal Health offering the simplest, most effective control of the challenging Mycoplasma respiratory disease in pheasants.
Specifically licensed for the treatment of mycoplasmosis in pheasants, ECO Animal Health’s Aivlosin 625mg/g is the first authorised soluble antibiotic for the control of Mycoplasma gallisepticum.
The soluble granules contain the unique macrolide antibiotic tylvalosin which has already excellent proven efficacy in the control of Mycoplasma infections in poultry. As the only fully licensed product for the treatment of Mycoplasmosis in pheasants the risk of having to resort to the cascade to find an unlicensed product to treat the condition is eliminated.
Clinical studies from the University of Liverpool showed that pheasants with Mycoplasmosis treated with tylvalosin (Aivlosin) in the drinking water for three days showed significantly improved performance, while previous work carried out by the University of Cambridge demonstrated how Aivlosin accumulates in various cell types more quickly and at higher concentrations than existing non-licensed antibiotics currently used in gamebirds.
Aivlosin is highly soluble and dosing either via traditional header tank application; automated systems such as Dosatrons or drinking vessels is recommended. The approved dosage rate for both Mycoplasma treatment is 25mg/kg for three consecutive days.
ECO Animal Health is launching Aivlosin in a convenient 16g pack size which will treat 1,000 x six-week-old poults for one of the three days medication.